CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma

Yanli Liu(National Institute for Radiological Protection), Jingqi Chen(Center for Excellence in Molecular Plant Sciences)
Frontiers in Immunology
September 27, 2022
Cited by 11


Related Papers